Gerald L. Klein serves as Executive at OXYGEN BIOTHERAPEUTICS, INC., where they oversee executive responsibilities. Since joining the company, Gerald L. Klein has executed 7 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 14, 2011 involved selling 243 shares valued at $508.
Gerald L. Klein currently holds 13,542 shares of OXYGEN BIOTHERAPEUTICS, INC. (OXBT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gerald L. Klein has been a net neutral trader of OXBT stock. They have purchased $0 and sold $0 worth of shares.
Gerald L. Klein's most recent insider trade was on Oct 14, 2011, when they sold 243 shares at $2.09 per share.
Get notified when new Form 4 filings are submitted
| $2.28 |
| Discretionary |
| Aug 10, 2011 | OXBT | $600 | Payment | 243 | $2.47 | Discretionary |
| Aug 4, 2011 | OXBT | $481 | Payment | 243 | $1.98 | Discretionary |
| Aug 4, 2011 | OXBT | $481 | Payment | 243 | $1.98 | Discretionary |
| Aug 4, 2011 | OXBT | $727 | Payment | 243 | $2.99 | Discretionary |
| May 27, 2011 | OXBT | $0 | Award | 7,500 | $N/A | Discretionary |